InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
0
T+90 hit rate
20%
T+90 mean return
-12.9%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Stewart Christopher P., Chief Financial Officer. Director active across 3 companies, notably Bionano Genomics, Inc. Aggregated, 7 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €31k. History available since 26 May 2021. The latest transaction was disclosed on 12 May 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
50,000 shares@ US$0.668336.0% of flowCommon StockSEC:0001411690-23-000031:0
Ideal exit: 6 Feb 2024 (T+270)
105,000 shares0Common StockSEC:0001209191-23-010918:0
60,000 shares@ US$0.560.20% mcap59.4% of flowCommon StockSEC:0001209191-22-029459:0
22,500 shares@ US$0.560.067% mcap20.3% of flowCommon StockSEC:0001209191-21-066283:0
22,500 shares@ US$0.5613.0% of flowCommon StockSEC:0001209191-21-066283
25,000 shares@ US$0.5650.0% of flowCommon StockSEC:0001209191-21-036254
25,000 shares@ US$0.560.070% mcap50.0% of flowCommon StockSEC:0001209191-21-036254:0
7 of 7 declarations
About Stewart Christopher P.
Christopher P. Stewart is the Chief Financial Officer at Bionano Genomics, Inc. He is responsible for the financial management of the company, including budgeting and performance analysis. With extensive experience in finance, he plays a key role in financial strategy and decision-making. His commitment to transparency and compliance is essential for Bionano Genomics' success.
